Moderna tests its Covid-19 vaccine on young children
Modern Inc. MRNA 4.87% began studying his Covid-19 vaccine in children aged six months to 11 years in the U.S. and Canada, the latest attempt to broaden the mass vaccination campaign beyond adults.…
